Elias Chalhub
Neurology · Mobile, ALNPI 1922043421
Payments from drug & device makers
Across 135 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$268
- AbbVie$233
- Supernus Pharmaceuticals, Inc.$189
- SK Life Science, Inc.$176
- UCB, Inc.$176
- EMD Serono, Inc.$106
- plus $1K from 32 others
What the payments were for
- Food & beverage$2,337100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 22 | $268 |
| AbbVie(2 entities) | 12 | $233 |
| Supernus Pharmaceuticals, Inc. | 14 | $189 |
| SK Life Science, Inc. | 6 | $176 |
| UCB, Inc. | 8 | $176 |
| EMD Serono, Inc. | 8 | $106 |
| Azurity Pharmaceuticals, Inc. | 4 | $99 |
| Acadia Pharmaceuticals Inc | 5 | $95 |
| Biogen | 5 | $86 |
| Argenx US, Inc. | 3 | $84 |
| Genentech USA, Inc. | 4 | $81 |
| Teva Pharmaceuticals USA, Inc. | 5 | $80 |
| AstraZeneca(2 entities) | 3 | $60 |
| Eisai Inc. | 2 | $45 |
| Lundbeck LLC | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 2 | $38 |
| Neurocrine Biosciences, Inc. | 2 | $36 |
| Neurelis, Inc. | 2 | $35 |
| Portola Pharmaceuticals, LLC | 2 | $32 |
| Baxter Healthcare | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
| Springworks Therapeutics, Inc. | 1 | $29 |
| Pfizer | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 2 | $29 |
| Johnson & Johnson | 2 | $27 |
| Tanabe Pharma America, Inc. | 1 | $22 |
| Upsher-smith Laboratories LLC | 1 | $21 |
| Sanofi | 1 | $18 |
| Amgen | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Acorda Therapeutics, Inc | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Merz North America, Inc. | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
| Zogenix Inc. | 1 | $11 |
| Aucta Pharmaceuticals, Inc. | 1 | $10 |
How this compares
$2,337 in reported general payments places this provider in the 45th percentile of 255 neurology providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbamazepine ErCarbamazepine | 19 | $4,499 |
| Phenobarbital | 18 | $1,135 |
| Divalproex Sodium ErDivalproex Sodium | 23 | $1,122 |
| Levetiracetam | 40 | $857 |
| Phenytoin Sodium Extended | 13 | $730 |
| Risperidone | 17 | $414 |
| Oxcarbazepine | 16 | $377 |
| Phenytoin | 13 | $328 |
| Baclofen | 15 | $220 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 14 | $154 |
| Gabapentin | 13 | $142 |
Paid to pharmacies, not to this prescriber.
Other neurology in Mobile
- Daniel DeesMobile$894K
- Hayden LongMobile$386K
- William KilgoMobile$334K
- John HintonMobile$270K
- Charles MarkleMobile$212K
- Bassam BassamMobile$197K
- Dean NaritokuMobile$164K
- Matthew McLeanMobile$113K
- Laura MintoMobile$92K
- Steve CordinaMobile$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.